Most Popular
Download Read
Clinical study using mesenchymal stem cells for the treatment of patients with severe COVID-19
Lingling Tang, Yingan Jiang, Mengfei Zhu, Lijun Chen, Xiaoyang Zhou, Chenliang Zhou, Peng Ye, Xiaobei Chen, Baohong Wang, Zhenyu Xu, Qiang Zhang, Xiaowei Xu, Hainv Gao, Xiaojun Wu, Dong Li, Wanli Jiang, Jingjing Qu, Charlie Xiang, Lanjuan Li
7 Aug 2020 | Frontiers of Medicine
Effects and mechanisms of acupuncture on women related health
30 Dec 2023 | Frontiers of Medicine
Bacteria-mediated tumor-targeted delivery of tumstatin (54-132) significantly suppresses tumor growth in mouse model by inhibiting angiogenesis and promoting apoptosis
17 Oct 2022 | Frontiers of Medicine
Advances in COVID-19: the virus, the pathogenesis, and evidence-based control and therapeutic strategies
Guangbiao Zhou, Saijuan Chen, Zhu Chen
21 Apr 2020 | Frontiers of Medicine
Treatment of advanced non-small cell lung cancer with driver mutations: current applications and future directions
28 Feb 2023 | Frontiers of Medicine
Plasma soluble C-type lectin-like receptor-2 is associated with the risk of coronary artery disease
Min Fei, Li Xiang, Xichen Chai, Jingchun Jin, Tao You, Yiming Zhao, Changgeng Ruan, Yiwen Hao, Li Zhu
11 Dec 2019 | Frontiers of Medicine
CAR T cells redirected against tumor-specific antigen glycoforms: can low-sugar antigens guarantee a sweet success?
25 Jun 2022 | Frontiers of Medicine
Association of gene variants with juvenile amyotrophic lateral sclerosis
19 Oct 2023 | Frontiers of Medicine
Discovery of small molecule degraders for modulating cell cycle
10 Nov 2023 | Frontiers of Medicine
Metabolic interventions combined with CTLA-4 and PD-1/PD-L1 blockade for the treatment of tumors: mechanisms and strategies
2 Nov 2023 | Frontiers of Medicine
Latest Research More>>
Regulations of mA and other RNA modifications and their roles in cancer
Frontiers of Medicine doi: 10.1007/s11684-024-1064-8
Frontiers of Medicine doi: 10.1007/s11684-024-1065-7
Frontiers of Medicine doi: 10.1007/s11684-023-1053-3
Frontiers of Medicine doi: 10.1007/s11684-023-1054-2
Frontiers of Medicine doi: 10.1007/s11684-024-1073-7
Frontiers of Medicine doi: 10.1007/s11684-024-1063-9
Moderate expression of CD39 in GPC3-CAR-T cells shows high efficacy against hepatocellular carcinoma
Frontiers of Medicine doi: 10.1007/s11684-024-1071-9
Frontiers of Medicine 2024, Volume 18, Issue 3, Pages 484-498 doi: 10.1007/s11684-023-1036-4